openPR Logo
Press release

Lawsuit filed for Investors in shares of Sema4 Holdings Corp. (NASDAQ: SMFR) over alleged Securities Laws Violations

09-13-2022 08:44 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Sema4 Holdings Corp. (NASDAQ: SMFR) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in Sema4 Holdings Corp. (NASDAQ: SMFR) shares over alleged securities laws violations.

An investor, who purchased shares of Sema4 Holdings Corp. (NASDAQ: SMFR), filed a lawsuit over alleged violations of Federal Securities Laws by Sema4 Holdings Corp.

Investors who purchased shares of Sema4 Holdings Corp. (NASDAQ: SMFR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 7, 2022. NASDAQ: SMFR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Stamford, CT based Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data.

On February 10, 2021, -Sema4 and CM Life Sciences (Nasdaq: CMLF) announced they have entered into a definitive business combination agreement. Under the terms of the agreement, CM Life Sciences shareholders will retain ownership of only 17% of the combined company.

On July 22, 2021, CM Life Sciences, Inc., a special purpose acquisition company, completed its business combination with Mount Sinai Genomics, Inc., and the combined public entity was renamed Sema4 Holdings Corp.

On June 14, 2022, Sema4 Holdings Corp announced that its Chief Financial Officer had departed.

On August 15, 2022, after the market closed, Sema4 Holdings Corp announced changes to its research and development leadership team, including that its founder was stepping down from the organization and leaving his role as President and Chief R&D Officer. The Company also disclosed that it was eliminating approximately 13% of its workforce as part of a series of restructuring and corporate realignments. Additionally, Sema4 lowered its fiscal 2022 revenue guidance to $245 million to $255 million from its prior guidance of $305 million to $315 million.

Shares of Sema4 Holdings Corp. (NASDAQ: SMFR) declined from $10.305 per share on September 2, 2021, to $1.11 per share on August 23, 2022.

The plaintiff claims that between March 14, 2022 and August 15, 2022, the Defendants failed to disclose to investors that there was a significant risk that Sema4 would reverse a material amount of previously recognized revenue that it could not recoup from third party payors, that the Company was experiencing declining selling prices for its reproductive health segment, that, as a result of the foregoing, Sema4's financial results would be adversely affected, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Sema4 Holdings Corp. (NASDAQ: SMFR) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Sema4 Holdings Corp. (NASDAQ: SMFR) over alleged Securities Laws Violations here

News-ID: 2733472 • Views: 313

More Releases from Shareholders Foundation

Investigation announced for Investors who lost Money with their shares in Roblox …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Roblox Corporation. Investors who purchased shares of Roblox Corporation (NYSE: RBLX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Roblox directors breached their fiduciary duties and caused damage to the company and its shareholders. San Mateo, CA based Roblox Corporation develops
Investigation announced for Investors in Waterdrop Inc. (NYSE: WDH) over possibl …
An investigation was announced over potential securities laws violations by Waterdrop Inc. in connection with certain financial statements. Investors who purchased shares of Waterdrop Inc. (NYSE: WDH), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Waterdrop Inc. (NYSE: WDH regarding its business, its prospects and its operations were materially
Sinovac Biotech Ltd. (formerly NASDAQ: SVA) Investor Notice: Deadline in Lawsuit …
A deadline is coming up on October 17, 2022 in the lawsuit filed for certain investors of Sinovac Biotech Ltd. (formerly NASDAQ: SVA) over alleged securities laws violations by Sinovac Biotech Ltd. Investors who purchased shares of Sinovac Biotech Ltd. (formerly NASDAQ: SVA) have certain options and there are strict and short deadlines running. Deadline: October 17, 2022. Sinovac Biotech Ltd. (formerly NASDAQ: SVA) stockholders should contact the Shareholders Foundation at
Investigation announced for Investors in Anaplan, Inc. (NYSE: PLAN) over potenti …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Anaplan, Inc. Investors who are current long term investors in Anaplan, Inc. (NYSE: PLAN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: PLAN stocks follows a lawsuit filed against Anaplan, Inc. over

All 5 Releases